Literature DB >> 21455583

Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.

Soon Young Park1, Ji Ae Jun, Kang Jin Jeong, Hoi Jeong Heo, Jang Sihn Sohn, Hoi Young Lee, Chang Gyo Park, Jaeku Kang.   

Abstract

Histone deacetylases (HDACs) are associated with the development and progression of cancer, but it is not known which of the HDAC isoforms play important roles in breast cancer metastasis. This study identified the specific HDAC isoforms that are necessary for invasion and/or migration in human breast cancer cell lines. MDA-MB-231 cells were significantly more invasive and expressed higher levels of matrix metalloproteinase-9 (MMP-9) compared to MCF-7 cells. We compared the expression of HDAC isoforms between MCF-7 and MDA-MB-231 cells and found greater expression of HDAC4, 6 and 8 in MDA-MB-231 cells by RT-PCR and Western blot analyses. In addition, apicidin, a histone deacetylase inhibitor, was shown to attenuate the invasion, migration and MMP-9 expression in MDA-MB-231 cells. Using specific siRNAs directed against HDAC1, 4, 6 and 8, we show that inhibition of HDAC1, 6 and 8, but not HDAC4, are responsible for invasion and MMP-9 expression in MDA-MB-231 cells. We analyzed the invasiveness of MCF-7 cells overexpressing HDAC1, 4, 6 or 8 and found that overexpression of HDAC1, 6 or 8 increased invasion and MMP-9 expression. By developing HDAC isoforms as potential biomarkers for breast cancer metastasis, the present study can be extended to developing therapies for breast cancer invasion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455583     DOI: 10.3892/or.2011.1236

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  57 in total

1.  Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.

Authors:  J Zhang; X Qin; Q Sun; H Guo; X Wu; F Xie; Q Xu; M Yan; J Liu; Z Han; W Chen
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

2.  β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells.

Authors:  Thoria Donia; Mohamed Abouda; Mohamed Kelany; Mohamed Hessien
Journal:  Med Oncol       Date:  2021-03-15       Impact factor: 3.064

3.  MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.

Authors:  Ying Wang; Po Xu; Jun Yao; Ruina Yang; Zhenguo Shi; Xiaojuan Zhu; Xiaoshan Feng; Shegan Gao
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

4.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

5.  HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.

Authors:  Panpan An; Feng Chen; Zihan Li; Yuyi Ling; Yanxi Peng; Haisheng Zhang; Jiexin Li; Zhuojia Chen; Hongsheng Wang
Journal:  Oncogene       Date:  2020-06-04       Impact factor: 9.867

Review 6.  Histone deacetylases and cancer.

Authors:  Bruna Barneda-Zahonero; Maribel Parra
Journal:  Mol Oncol       Date:  2012-08-27       Impact factor: 6.603

Review 7.  Histone deacetylases as targets for treatment of multiple diseases.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

8.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.

Authors:  Tint Lwin; Xiaohong Zhao; Fengdong Cheng; Xinwei Zhang; Andy Huang; Bijal Shah; Yizhuo Zhang; Lynn C Moscinski; Yong Sung Choi; Alan P Kozikowski; James E Bradner; William S Dalton; Eduardo Sotomayor; Jianguo Tao
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

10.  Fluorescent polymer-based post-translational differentiation and subtyping of breast cancer cells.

Authors:  Michael D Scott; Rinku Dutta; Manas K Haldar; Anil Wagh; Thomas R Gustad; Benedict Law; Daniel L Friesner; Sanku Mallik
Journal:  Analyst       Date:  2012-10-12       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.